FDA
- Marketing authorisation holder: BRACCO
- Status: approved
Guna-Geriatrics (BARIUM) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
BRACCO holds the US marketing authorisation.